Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature
- PMID: 18094971
- PMCID: PMC2292418
- DOI: 10.1007/s00296-007-0504-5
Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature
Abstract
Idiopathic hypertrophic cranial pachymeningitis (IHCP) is a rare clinical entity, characterized by a chronic inflammation causing thickening of the dura. Adequate therapeutic management is still a matter of debate. We present a patient with an IHCP, non-responsive to corticotherapy. Oral methotrexate was introduced (12.5 mg weekly) and total remission was observed after 6 weeks, both clinically and after neuro-imaging. We conclude that methotrexate can be effective and a therapeutical option in patients with IHCP who are resistant to corticotherapy or present major side-effects of chronic corticosteroids use.
Figures
References
-
- Charcot JM, Joffroy A (1869) Deux cas d’athrophie musculaire progressive avec lésions de la substance gris et des faisceaux antériolatéraux de la melle épinière. Arch Physiol Norm Pathol 2:354–367, 629–649, 744–769
-
- Naffziger HC, Stern WE (1949) Chronic pachymeningitis: report of a case and review of the literature. Arch Neurol Psychiatry 62:383–411 - PubMed
-
- Sylaja PN, Cherian PJ, Das CK, Radhakrishnan VV, Radhakrishnan K (2002) Idiopathic hypertrophic cranial pachymeningitis. Neurol India 50:53–59 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
